Instead, mutations in KRAS, or more commonly BRAF, activate the RAS–RAF–MEK–ERK–MAPK axis as these are the earliest mutations observed in sessile serrated adenomas and its precursor hyperplastic polyps [76–84] (Figure 2). The gene discussed is BRAF; the disease is adenoma.